SHIHO KOJIMA: Open Payments
NPI 1902564396 · LAGUNA HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 28 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $189 |
| Merck Sharp & Dohme LLC | 5 | $154 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Amgen Inc. | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| SCPHARMACEUTICALS INC. | 1 | $36 |
| Medtronic, Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
Products named: VERQUVO, Ozempic, REPATHA, Wegovy, Kerendia, AMVUTTRA, JARDIANCE, FUROSCIX.
Industry payments across CA — which companies pay providers there.
